Kumar Bishwajit Sutradhar

Dr. Kumar Bishwajit Sutradhar

Department of Pharmacy, Stamford University Bangladesh, Dhaka, Bangladesh
+1
orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in ISRN Nanotechnology
Verified
Journal Article
Open access
PDF file
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
LALutful Amin
Lutful Amin
Nanoparticles are rapidly being developed and trialed to overcome several limitations of traditional drug delivery systems and are coming up as a distinct therapeutics for cancer treatment. Conventional chemotherapeutics possess some serious side effects including damage of the immune system and other organs with rapidly proliferating cells due to nonspecific targeting, lack of solubility, and inability to enter the core of the tumors resulting in impaired treatment with reduced dose and with low survival rate. Nanotechnology has provided the opportunity to get direct access of the cancerous cells selectively with increased drug localization and cellular uptake. Nanoparticles can be programmed for recognizing the cancerous cells and giving selective and accurate drug delivery avoiding interaction with the healthy cells. This review focuses on cell recognizing ability of nanoparticles by various strategies having unique identifying properties that distinguish them from previous anticancer therapies. It also discusses specific drug delivery by nanoparticles inside the cells illustrating many successful researches and how nanoparticles remove the side effects of conventional therapies with tailored cancer treatment.

8 May 2013 in European Journal of Nanomedicine
Verified
Journal Article
Closed access
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
LALutful Amin
Lutful Amin
Nanotechnology, the science of nano sized particles, has rapidly gained the spotlight in diversified areas including pharmaceutical sector. With the blessings of accurate drug designing and better pharmacological action, it has entered the pharmaceutical arena bringing promising discoveries along with it. Nanoemulsion is one of the greatest and advantageous dosage forms with the application of nanotechnology in pharmaceutical formulations. Very small size droplets of the nanoemulsion favor better drug absorption and targeting. It not only improves the conventional emulsion systems but also opens new opportunities for other drugs to be designed more precisely with better bioavailability and accurate dosing rendering minimum side effects. This article depicts various advantageous features of nanoemulsions delineating different methods of preparation. The foci of this review also include the opportunities of other drugs to be formulated through nanoemulsification in order to ensure better therapeutic effect. The summary shows recent researches on nanoemulsion formulation from different classes of drugs as well as some formulations based on nanoemulsion templates. The methods of preparing nanoparticles, characterized by nanoemulsion templates, have also been discussed which, as a whole, presents the best possibilities of nanoemulsions.

24 April 2014 in Drug Delivery
Verified
Journal Article
Closed access
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
CSChandra Datta Sumi
Chandra Datta Sumi
There is no doubt that controlled and pulsatile drug delivery system is an important challenge in medicine over the conventional drug delivery system in case of therapeutic efficacy. However, the conventional drug delivery systems often offer a limited by their inability to drug delivery which consists of systemic toxicity, narrow therapeutic window, complex dosing schedule for long term treatment etc. Therefore, there has been a search for the drug delivery system that exhibit broad enhancing activity for more drugs with less complication. More recently, some elegant study has noted that, a new type of micro-electrochemical system or MEMS-based drug delivery systems called microchip has been improved to overcome the problems related to conventional drug delivery. Moreover, micro-fabrication technology has enabled to develop the implantable controlled released microchip devices with improved drug administration and patient compliance. In this article, we have presented an overview of the investigations on the feasibility and application of microchip as an advanced drug delivery system. Commercial manufacturing materials and methods, related other research works and current advancement of the microchips for controlled drug delivery have also been summarized.

11 April 2013 in Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
SKSabera Khatun
Sabera Khatun
ILIrin Parven Luna
Irin Parven Luna
Nowadays, a very large proportion of new drug candidates emerging from drug discovery programmes are water insoluble and thus poorly bioavailable. To avoid this problem, nanotechnology for drug delivery has gained much interest as a way to improve the solubility problems. Nano refers to particles size range of 1–1000 nm. The reduction of drug particles into the submicron range leads to a significant increase in the dissolution rate and therefore enhances bioavailability. Nanosuspensions are part of nanotechnology. This interacts with the body at subcellular (i.e., molecular) scales with a high degree of specificity and can be potentially translated into targeted cellular and tissue-specific clinical applications designed to achieve maximal therapeutic efficacy with minimal side effects. Production of drugs as nanosuspensions can be developed for drug delivery systems as an oral formulation and nonoral administration. Here, this review describes the methods of pharmaceutical nanosuspension production including advantages and disadvantages, potential benefits, characterization tests, and pharmaceutical applications in drug delivery.

10 January 2014 in Annual Research & Review in Biology
Verified
Journal Article
Open access
PDF file
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
ASAnamika Saha
Anamika Saha
NHNaz Hasan Huda
Naz Hasan Huda
RURiaz Uddin
Riaz Uddin
Aims: Antibiotic resistance is one of the widely recognized public health challenges in Bangladesh. The present study was aimed to analyze the current status of irrational use of antibiotics in rural Bangladesh and to explore the views from both physicians’ and patients’ perspective. Study Design: Population based survey. Place and Duration of Study: The survey was conducted among 6,000 patients and 580 physicians in the rural areas of Dhaka and Rajshahi divisions of Bangladesh from July 2012 to December 2012. Methodology: The survey followed a face-to-face interview protocol. 24 Upazila Health Complexes and 112 Union Health Centers of Dhaka and Rajshahi divisions were conveniently surveyed by trained volunteer interviewers. Two separate survey questionnaires were developed for physician and patient survey. Results: From the physician survey it was found that significantly more doctors prescribe antibiotics in suspected infections (P<.0001). Around forty-four (44.1) percent doctors prescribe antibiotics in cold and fever before diagnosis. A significant proportion of physicians never receive any feedback about the antibiotic they prescribe (31.9%, P<.0001) and more than 50% doctors claimed that they receive feedback occasionally, not always (P<.0001). According to the physician’s patient non-compliance is the main cause of antibiotic resistance in the country (68.8%). Though 48.6% patients think that it is important to strictly follow the doctor’s prescription, a significant percentage believe that it is not always necessary (26.7%, P<.0001) and more than 50% patient stop taking the antibiotic as soon as the symptoms disappear, while only 25.2% patient complete their full course. Only 6.3% patients consult their doctor if they miss the dose of an antibiotic and more than 50% take the next dose on time (P<.0001). When a drug does not work the patient usually consider the doctor is incompetent (25.6%) and many (24.5%) believe that the quality of the drug is not up to the mark. Conclusion: The result of this survey indicates that the antibiotics are used among the rural people in irrational way. To overcome this situation close supervision of the relevant authority is required in order to minimize the growing antibiotic resistance in Bangladesh.

 in Stamford Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
RURiaz Uddin
Riaz Uddin
MWMoin Ibna Wahid
Moin Ibna Wahid
TJTasbira Jasmeen
Tasbira Jasmeen
NHNaz Hasan Huda
Naz Hasan Huda
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
Fish is an important food stuff and source of protein all over the world. In Bangladesh fisheries sector contributes a lot in case of earning foreign currency and meeting domestic need of animal protein. To meet the domestic need Bangladesh imports fish and fish products from neighboring countries. But it is evident from several studies that fish items in Bangladesh contain formalin which is a highly hazardous and carcinogenic chemical. An attempt was taken to detect the extent of formalin use in fish available in Dhaka city. From five different local markets five species of fishes were collected and presence of formalin was detected using the “formalin detection kit in fish” developed by Bangladesh Council of Scientific and Industrial Research (BCSIR). The study indicates that 70% Rui fish is formalin contaminated and almost 50% of fish samples contain formalin. Key words: Formaldehyde; BCSIR; Formalin detection kit; Carcinogen; Fisheries; Livestock. DOI: http://dx.doi.org/10.3329/sjps.v4i1.8866 SJPS 2011; 4(1): 49-52